Джейн Плант - Антирак груди

737

Edwards, T.T., 2006. Reproductive dysgenesis in wildlife: a comparative view. International Journal of Andrology, 29 (1), 109–121; Guillette, L.L., 1999. Plasma steroid concentrations and male phallus size in juvenile alligators from seven Florida lakes. General and Comparative Endocrinology, 116(3), 356–372.

738

Colborn, T., Dumanoski, D. and Myers, J.P., 1996. Our Stolen Futures, Dutton, Penguin Books, USA.

739

Webb, S.F., 2000. Risk assessment approaches for Pharmaceuticals. In: International Seminar: Pharmaceuticals in the Environment, Technological Institute, Section on Environmental Technology, Brussels, 2000.

740

Kolpin, D.A., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B. and Buxton, H.T.; 2002. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in US Streams, 1999–2000: A National Reconnaissance. Environmental Science & Technology, 36, 1202–1211.

741

McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, T.H., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, http://www.nmenv.state.nm.us/gwb/drugs.html; Morelli, J., 2000. Are Our Medicines Tainting the Environment? http://webmd.lycos.com/content/article/25/1728_58159?

742

McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, T.H., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, http://www.nmenv.state.nm.us/gwb/drugs.html

743

The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24.

744

Hamburger Umwelt Institute, 1997. Poor Design Practices – gaseous emissions form complex products.

745

Brown, S.K. and Cheng, M., 2000. Volatile Organic Compounds (VOCs) in New Car Interiors. Presented at the 35th International Clean Air & Environment Conference Sydney, 26–30 November 2000.

746

http://www.le.ac.uk/ieh

747

Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.

748

The Globe and Mail, November 22, 2002, page A5. Data point to breast-cancer risk. By Martin Mittelstaedt.

749

Newby, J.A. and Howard, C.V., 2006. Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine; 2006, 1-59.

750

Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.

751

Birnbaum, L.S. and Fenton, S.E., 2003. Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives, 11 (4), 389–395.

752

www.obgyn.nct/newsrx/womens_health-Colorectal_Cancer-20001214-7.asp

753

http://info.cancerresearchuk.org/healthyliving/dietandhealthycating/theepicstudy

754

www.ucdmc.ucdavis.edu/ucdhs/health/a-z/06BreastCancer/doc06lowerisk.html

755

Epidem. 1994, 23 (6), 1133–1136.

756

Spurgeon, D., 2006. Vitamin D is associated with a lower risk of cancer. BMJ, 332, 70.

757

Miller, W.R. and Sharpe, R.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer, 5, 69–96.

758

http://cis.nci.nih.gov/fact/3_13.htm

759

Gottlieb, Scott. 2002. Study supports evidence on oral contraception and breast cancer. BMJ, 325, 6 July 2002, 8.

760

Writing Group for the Women's Health Initiative Investigators. 2002. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Journal of the American Medical Association, 288, № 3.

761

Collaborative Group on Hormonal Factors in Breast Cancer, 1997. Breast cancer and hormone replacement therapy. Lancet, 350, 1047–1059.

762

Schairer, C., Lubin, J., Troisi, R., and others, 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA, 283(4), 485–491.

763

www.nih.gov/news/pr/nov2002/nichd-29.htm

764

Ross, R.K., Paganini-Hill, A., Wan, P.C. and others, 2000. Effective hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl Cancer Inst, 92, 328–332. Schairer, C., Lubin, J., Troisi, R. and others. 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA, 283 (4), 485–491.

765

The Times. 15 December 2006.

766

Ernst, E (editor), 2001. The Desktop Guide to Complementary and Alternative Medicine: an evidence based approach. Mosby.

767

Lee, John R, 1999. Natural Progesterone. Second revised edition. Jon Carpenter.

768

Cowan, L.D., Gordis, L., Tonascia, J.A. and Jones, G.S., 1981. Breast cancer incidence in women with a history of progesterone deficiency. Am. J. Epidemiology, 114, 209–217.

769

Hrushesky, W.J.M., 1996. Breast cancer, timing of surgery, and the menstrual cycle: call for prospective trial. J. Women's Health, 5, 555–566.

770

Mohr, P.E., Wang, D.Y., Gregory, W.M., Richards, M.A. and Fentiman, I.S., 1996. Serum progesterone and prognosis in operable breast cancer. British J. Cancer, 73, 1552–1555.

771

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

772

Dibble, S.L. and others, 2002. Risk factors for ovarian cancer; lesbian and heterosexual women. Oncol Nursing Forum, 29 (1), El-7.

773

Ives, A. and Semmens, J., 2007. Pregnancy after breast cancer: population based study. BMJ, 334, 194.

774

www.cancer.org/docroot/cri/content/cri_2_4_5x_what_happens_after_treatment_5.asp?sitearea=cr

775

http://www.cancer.org/docroot/cri/content/cri_2_6x_can_having_an_abortion_cause_or_contribute_to_breast_cancer.asp

776

http://www.cancer.org/docroot/cri/content/cri_2_6x_can_having_an_abortion_cause_or_contribute_to_breast_cancer.asp

777

www.cspinet.org/new/200206251.html

778

Campbell, T., Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.

779

Kannel W.B. and others, 1961. Factors of risk in the development of coronary heart disease – six year follow up experience. Anna. Internal medi., SS.

780

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.

781

Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. American Journal of Clinical Nutrition, 59 (Suppl.), 11 535–11 615.

782

Marwick, Charles, 2003. Food industry obfuscates healthy eating message, BMJ, 327, 121.

783

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006, The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.

784

Schlosser, Eric, 2002. Fast Food Nation. Penguin Books.

785

Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine, 21 July 2002, 46–54.

786

Mercer, Chris, 2007. EU unveils milk shake-up plans, www.foodnavigator.com